Gilead Sciences Inc.s (GILD) remdesivir, its coronavirus drug candidate, is most beneficial for Covid-19 patients who require supplemental oxygen but dont need mechanical ventilation, according to a …
Read More
Gilead Sciences Inc.s (GILD) remdesivir, its coronavirus drug candidate, is most beneficial for Covid-19 patients who require supplemental oxygen but dont need mechanical ventilation, according to a …
Read More